Hyman is also the founder of Function Health, a new personal health platform that makes lab testing, advanced MRI and CT scans, and longitudinal health data accessible and understandable
Catanese L, LeWine HE
Treatment with semaglutide 0.5 mg and 1 mg once weekly for 56 weeks resulted in a statistically significant reduction in HbA 1c compared to sitagliptin (see Table 4 and Figure 5)
2024 DOI: 10.1038/s41421-024-00702-y PMID: 39019866 Read on PubMed European Journal of Clinical Pharmacology A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Kaur M, Misra S 2024 DOI: 10.1007/s00228-024-03646-0 PMID: 38367045 Read on PubMed Cardiology in Review The First Triple Agonist for Antiobesity: Retatrutide Tetelbaum L, Mullally JA, Frishman WH 2024 DOI: 10.1097/CRD.0000000000000793 PMID: 39724554 Read on PubMed NPJ Metabolic Health and Disease Incretin triple agonist retatrutide alleviates obesity-associated cancer progression Marathe SJ, Grey EW, Bohm MS, et al
HealthyHey Nutrition products are manufactured in FSSAI-certified, GMP (TV India) verified, and FSSC 22000 V6 certified facilities